TNFRSF4 and cancer: While cancer cells showed no expression of OX40, the surface OX40 protein was detected in 7.5% of immune cells, 19.4% of T cells, 9.3% of cytotoxic T cells (CD8+), and 4.5% of non-T leukocytes.